Paper - WANFANG MED ONLINE

You Position: Home > Paper

Expert consensus of Oncology Committee of Chinese Medical Association in early diagnosis and treatment of pancreatic cancer

( views:502, downloads:983 )

Author:: No author available

Journal Title:: Chinese Journal of Oncology

Issue:: 9

DOI:: 10.3760/cma.j.cn112152-20200508-00426

Key Word:: 胰腺肿瘤;早期诊断;早期治疗;共识;Pancreatic neoplasms;Early diagnosis;Early treatment;Consensus

Abstract： Pancreatic cancer(PC) remains one of the most challenging malignant tumor in gastrointestinal cancer, and the incidence and mortality rates are significantly increased in the past decades. The 5-years survival rate of PC is less than 8% since its dormant clinical symptoms and lacking of sensibility and specificity markers in early diagnosis. The early diagnosis of pancreatic cancer is a worldwide problem, and the early diagnosis rate is only 5%. Increasing early diagnosis rate is the key to improve the overall prognosis of pancreatic cancer. The key of early diagnosis and treatment of pancreatic cancer is to identify the high-risk population of pancreatic cancer, improve the sensitivity and specificity of early diagnosis technology, standardize the process of early diagnosis of pancreatic cancer, and standardize the treatment of early pancreatic cancer. To this end, this expert consensus is formulated.

Reference

[1]詹海勇,黄聪武,林銮群,等.血清糖链抗原19-9和糖链抗原242诊断胰腺癌的临床价值[J].2006,(3).
[2]郑荣寿,孙可欣,张思维,等.2015年中国恶性肿瘤流行情况分析[J].2019,(1).
[3]Hirsch,F.W.,Sattler,B.,Sorge,I.,etc.PET/MR in children. Initial clinical experience in paediatric oncology using an integrated PET/MR scanner[J].2013,43(7).
[4]Kaur,S.,Sasson,A.R.,Batra,S.K.,etc.Early diagnosis of pancreatic cancer: Challenges and new developments[J].2012,6(5).
[5]Edil BH,Rangachari D,Arnaoutakis GJ,etc.Pulmonary resection for isolated pancreatic adenocarcinoma metastasis: an analysis of outcomes and survival.[J].2011,15(9).
[6]Julie, Earl,Sandra, Garcia-Nieto,Jose Carlos, Martinez-Avila,etc.Circulating tumor cells (Ctc) and kras mutant circulating free Dna (cfdna) detection in peripheral blood as biomarkers in patients diagnosed with exocrine pancreatic cancer.[J].2015,15.
[7]Fattahi R,Perman WH,Balci NC,etc.Pancreatic diffusion-weighted imaging (DWI): comparison between mass-forming focal pancreatitis (FP), pancreatic cancer (PC), and normal pancreas.[J].2009,29(2).
[8]Yonehara,S.,Iiboshi,T.,Hanada,K.,etc.Value of cytodiagnosis using endoscopic nasopancreatic drainage for early diagnosis of pancreatic cancer: Establishing a new method for the early detection of pancreatic carcinoma in situ[J].2012,41(4).
[9]Katherine E Poruk,D Z Gay,K Brown,etc.The Clinical Utility of CA 19-9 in Pancreatic Adenocarcinoma: Diagnostic and Prognostic Updates.[J].2013,13(3).
[10]Siegel Rebecca L.,Miller Kimberly D.,Jemal Ahmedin.Cancer statistics, 2020[J].2020,70(1).
[11].Pancreatic adenocarcinoma: diagnosis and staging using multidetector-row computed tomography (MDCT) and magnetic resonance imaging (MRI)[J].2007.
[12]Li,X.,Guo,X.,Li,H.,etc.Serum carbohydrate antigen 242 expression exerts crucial function in the diagnosis of pancreatic cancer[J].2014,35(6).
[13]N C, Buchs,J L, Frossard,A, Rosset,etc.Vascular invasion in pancreatic cancer: evaluation of endoscopic ultrasonography, computed tomography, ultrasonography, and angiography.[J].2007,137(19-20).
[14]Jonathan R. Brody,Agnieszka K. Witkiewicz,Charles J. Yeo.The Past, Present, and Future of Biomarkers: A Need for Molecular Beacons for the Clinical Management of Pancreatic Cancer[J].2011,45(1).
[15]Hongmei Zeng,Wanqing Chen,Rongshou Zheng,etc.Changing cancer survival in China during 2003-15: a pooled analysis of 17 population-based cancer registries[J].2018,6(5).
[16]Caletti G,Mancino MG,Spada A,etc.Contrast harmonic echo-endoscopic ultrasound improves accuracy in diagnosis of solid pancreatic masses.[J].2010,8(7).
[17]Gandolfi L,Torresan F,Solmi L,etc.The role of ultrasound in biliary and pancreatic diseases.[J].2003,16(3).
[18]Nakatani Y,Morimoto M,Ueno N,etc.Contrast-enhanced sonography of small pancreatic mass lesions.[J].2002,21(9).
[19]Luo, Guopei,Liu, Chen,Guo, Meng,etc.Potential Biomarkers in Lewis Negative Patients With Pancreatic Cancer[J].2017,265(4).
[20]Siddiqui,A.A.,Mehendiratta,V.,Loren,D.,etc.Self-expanding metal stents (SEMS) for preoperative biliary decompression in patients with resectable and borderline-resectable pancreatic cancer: Outcomes in 241 patients[J].2013,58(6).
[21]Ahn SS,Kim MJ,Choi JY.Indicative findings of pancreatic cancer in prediagnostic CT.[J].2009,19(10).
[22]Miller Kimberly D.,Siegel Rebecca L.,Jemal Ahmedin.Cancer statistics, 2018[J].2018,68(1).
[23]Xiao, GuangQin,Guo, XingJun,Qin, RenYi,etc.Systematic review and meta-analysis of minimally invasive versus open approach for pancreaticoduodenectomy[J].2016,30(12).
[24]Itoh,Y.,Ishigami,M.,Goto,H.,etc.Malignant transformation of branch duct-type intraductal papillary mucinous neoplasms of the pancreas based on contrast-enhanced endoscopic ultrasonography morphological changes: Focus on malignant transformation of intraductal papillary mucinous neoplasm[J].2012,41(6).
[25]Sausen, Mark,Phallen, Jillian,Adleff, Vilmos,etc.Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patients[J].2015,6(Jul.).
[26]Gu Yu-Lei,Lan Chao,Pei Hui,etc.","Applicative Value of Serum CA19-9, CEA, CA125 and CA242 in Diagnosis and Prognosis for Patients with Pancreatic Cancer Treated by Concurrent Chemoradiotherapy[J].2015,16(15).
[27]Luis A Diaz,Alberto Bardelli.Liquid biopsies: genotyping circulating tumor DNA.[J].2014,32(6).
[28]Banke, Agarwal,Emad, Abu-Hamda,Kimber L, Molke,etc.Endoscopic ultrasound-guided fine needle aspiration and multidetector spiral CT in the diagnosis of pancreatic cancer.[J].2004,99(5).
[29]Feng, Cao,Jia, Li,Ang, Li,etc.Radical antegrade modular pancreatosplenectomy versus standard procedure in the treatment of left-sided pancreatic cancer: A systemic review and meta-analysis.[J].2017,17(1).
[30]Michael C, Garofalo,Elizabeth M, Nichols,William F, Regine.Optimal adjuvant therapy for resected pancreatic cancer: chemotherapy or chemoradiotherapy?[J].2007,1(5).
[31]Tong,X.,Xiao,D.,Yao,F.,etc.Astragalus membranaceus as a cause of increased CA19-9 and liver and kidney cysts: A case report[J].2014,39(5).
[32]Ross E,Hoffman JP,Watson JC,etc.Is reporting of recurrence data important in pancreatic cancer?[J].2004,11(3).
[33]Treadwell, Jonathan R.,Zafar, Hanna M.,Mitchell, Matthew D.,etc.Imaging Tests for the Diagnosis and Staging of Pancreatic Adenocarcinoma A Meta-Analysis[J].2016,45(6).
[34]Hirooka Y,Goto H,Ito A,etc.Recent advances in US diagnosis of pancreatic cancer.[J].2001,48(40).
[35]Cohen, Joshua D.,Javed, Ammar A.,Thoburn, Christopher,etc.Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers[J].2017,114(38).
[36]Liu H.,·Sun B.,·Wang S.,etc.Circulating Tumor Cells as a Biomarker in Pancreatic Ductal Adenocarcinoma[J].2017,42(1).
[37]Das Koushik K.,Early Dayna.Pancreatic Cancer Screening[J].2017,15(4).